MedTrace Logo

Substance Dependent Teens - Impact of Treating Depression Study 1 - 1

NCT00061113 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of treating depression on substance dependent teens.

Conditions

  • Alcohol-Related Disorders
  • Marijuana Abuse
  • Substance-Related Disorders

Interventions

DRUG

Fluoxetine + outpatient cognitive behavioral therapy

single fixed morning dose 20 mg X 15 weeks

DRUG

fluoxetine

20mg, QD x 16 weeks

DRUG

placebo + CBT

single fixed morning dose X 16 weeks

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Paula Riggs, M.D. · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2006-08-31
Completion
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00061113 on ClinicalTrials.gov